Journal ArticleOPEN ACCESS

Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer

Oncologist (2022) 27 S17-S18
DOI: 10.1093/oncolo/oyac014
11Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Jacobson, A. (2022). Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer. Oncologist, 27, S17–S18. https://doi.org/10.1093/oncolo/oyac014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free